Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients? by Dzialowski, I, Puetz, V, Buchan, A, Demchuk, A, Hill, MD

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. by Dzialowski, I, Pexman, J, Barber, P, Demchuk, A, Buchan, A, Hill, MD

Does application of radio contrast media prior to thrombolysis impact thrombolytic effect in acute ischemic stroke? by Dzialowski, I, Puetz, V, Demchuk, A, Buchan, A, Hill, MD, Grp, C

Tissue Window in Stroke Thrombolysis study (TWIST): a safety study. by Hill, MD, Kenney, C, Dzialowski, I, Boulanger, J, Demchuk, A, Barber, P, Watson, T, Weir, N, Buchan, A